PharmaShots | Incisive News in 3 Shots

Subscribe Now

Third

Celltrion Launches its Third Biosimilar Truxima (biosimilar- rituximab) in Brazil

Celltrion Launches its Third Biosimilar Truxima (biosimilar- rituximab) in Brazil

May 27, 2020

Hope Biosciences Reports its Third US FDA's Approval for Clinical Trial in COVID-19

Hope Biosciences Reports its Third US FDA's Approval for Clinical Trial in COVID-19

April 22, 2020

PharmaShots' Key Highlights of Third Quarter 2019

PharmaShots' Key Highlights of Third Quarter 2019

September 7, 2019

Eli Lilly's Taltz (ixekizumab) Receives Third US FDA's Approval for Active Ankylosing Spondylitis (Radiographic Axial Spondyloarthritis)

Eli Lilly's Taltz (ixekizumab) Receives Third US FDA's Approval for Active Ankylosing Spondylitis (Radiographic Axial Spondyloarth...

August 27, 2019

Merck and Eisai's Keytruda (pembrolizumab) + Lenvima (lenvatinib) Receive FDA's Third Breakthrough Therapy Designation as 1L Therapy for Hepatocellular Carcinoma

Merck and Eisai's Keytruda (pembrolizumab) + Lenvima (lenvatinib) Receive FDA's Third Breakthrough Therapy Designation as 1L Thera...

July 23, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us